A/Pr Rachel Codd
University of Sydney
Agents targeting iron in the brain in Parkinson's disease
National Health and Medical Research Council
The impaired coordination and tremors experienced by the 64,000 Australians with Parkinsons disease make managing life at work and home difficult. With 240,000 Australians projected to be living with Parkinsons disease by 2033, the discovery of agents that slow or stop disease progression is urgent. Iron in the brain has been implicated in Parkinsons disease. In this project, the performance of new low toxicity agents in altering brain iron distribution will be studied as potential drugs for Parkinsons disease.